Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled magnesium sulfate versus placebo in stable chronic obstructive pulmonary disease
ACTRN12608000502336Phase 3Recruiting
- Sponsor
- José Antônio Baddini Martinez MD, PhD
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by José Antônio Baddini Martinez MD, PhD. Primary endpoint: Change in forced expiratory volume in 1 second. Started Sep 2008; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12608000502336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000502336.